Layout table for study informationStudy Type:Interventional(Clinical Trial)EstimatedEnrollment:858 participantsAllocation:RandomizedIntervention Model:Parallel AssignmentMasking:Triple (Participant, Care Provider, Investigator)Primary Purpose:TreatmentOfficial Title:The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea (LOFT-HF)Actual Study Start Date:April 15, 2019Estimated Primary Completion Date:February 2023Estimated Study Completion Date:February 2023. HF disease-specific quality of life will be assessed by the change in the Kansas City Cardiomyopathy Questionnaire (KCCQ). The KCCQ quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life for those who have heart failure. An overall summary score is derived from the physical function, symptom (frequency and severity), social function and quality of life domains.
Oxygent Clinical Trials 2017
Scores are transformed to a range of 0-100, in which higher scores reflect better health status. Quality of Life and Symptoms - Generic-quality of life Time Frame: 12 months. Layout table for location informationUnited States, IllinoisNorthwestern University Feinberg School of MedicineRecruitingChicago, Illinois, United States, 60611Contact: Rosemary OrtizUniversity of ChicagoRecruitingChicago, Illinois, United States, 60637Contact: Linda EikelandUnited States, MissouriWashington University in St.